Literature DB >> 26550283

Predictive accuracy comparison of MELD and Child-Turcotte-Pugh scores for survival in patients underwent TIPS placement: a systematic meta-analytic review.

Chunze Zhou1, Changlong Hou1, Delei Cheng1, Wenjing Tang1, Weifu Lv1.   

Abstract

BACKGROUND: Child-Turcotte-Pugh (CTP) and the model for end-stage liver disease (MELD) scores have been used commonly to predict the survival in the patients with liver diseases underwent transjugular intrahepatic portosystemic shunt (TIPS). However, a debate has continued for years whether CTP could be replaced by MELD score. We performed a systematic meta-analytic review to compare the prediction capability of both scores in survival among patients with TIPS.
METHODS: Retrospective cohort studies among patients with TIPS were published as of May 2013 were identified by systematically searching four electronic literature database, such as Ovid Medline, PubMed, EMBASE, and ISI Web of Science. The difference of standardized mean difference (SMD) of c-statistics for the predictive accuracy of 1-, 3-, 6-, and 12-month survival for both MELD and CP scores, defined as effect size (ES), was calculated for each individual study and then pooled across studies using standard meta-analyses with a random effects model. Publication bias was evaluated using funnel plots and Kendall's rank correlation tests.
RESULTS: 174 researches articles or conference abstracts were searched and reviewed using the combination of relevant terms in the articles. Finally, 11 articles were defined as eligible studies to evaluate simultaneously the predictive accuracy of MELD and CTP scores. In the meta-analyses, MELD score was superior to CP score in predicting 3-month survival after TIPS (mean ES, 0.63; 95% confidence interval [CI], 0.13-1.14; P=0.01), but the predictive capability in 1-month, 6-month, and 12-month survival was not significant (1-month: mean ES, 0.79; 95% CI, -0.24-1.83; P=0.13; 6-month: mean ES, 0.46; 95% CI, -2.46-3.37; P=0.76; 12-month: mean ES, 0.36; 95% CI, -0.25-0.96; P=0.25).
CONCLUSIONS: No enough evidence are confirmed so far that MELD score is better than CTP score to assess the overall prognosis after TIPS, especially long-term predictions, but 3-month predictive capability of MELD score significantly outperform CTP score.

Entities:  

Keywords:  Child-Turcotte-Pugh (CTP) score; Transjugular intrahepatic portosystemic shunt (TIPS); meta-analysis; systematic review; the model for end-stage liver disease (MELD) score

Year:  2015        PMID: 26550283      PMCID: PMC4612968     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  43 in total

Review 1.  Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD.

Authors:  François Durand; Dominique Valla
Journal:  J Hepatol       Date:  2004-12-24       Impact factor: 25.083

2.  An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.

Authors:  Angelo Luca; Berhard Angermayr; Guido Bertolini; Franz Koenig; Giovanni Vizzini; Martin Ploner; Markus Peck-Radosavljevic; Bruno Gridelli; Jaime Bosch
Journal:  Liver Transpl       Date:  2007-08       Impact factor: 5.799

3.  MELD fails to measure quality of life in liver transplant candidates.

Authors:  Sammy Saab; Ayman B Ibrahim; Alexander Shpaner; Zobair M Younossi; Cindy Lee; Francisco Durazo; Steven Han; Karl Esrason; Victor Wu; Jonathan Hiatt; Douglas G Farmer; R Mark Ghobrial; Curtis Holt; Hasan Yersiz; Leonard I Goldstein; Myron J Tong; Ronald W Busuttil
Journal:  Liver Transpl       Date:  2005-02       Impact factor: 5.799

4.  Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.

Authors:  Alexander Zipprich; Oliver Kuss; Sebastian Rogowski; Gerhard Kleber; Erich Lotterer; Thomas Seufferlein; Wolfgang E Fleig; Matthias M Dollinger
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

Review 5.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

6.  Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.

Authors:  Ron C Gaba; Patrick M Couture; James T Bui; M Grace Knuttinen; Natasha M Walzer; Eric R Kallwitz; Jamie L Berkes; Scott J Cotler
Journal:  J Vasc Interv Radiol       Date:  2013-01-09       Impact factor: 3.464

7.  Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.

Authors:  Hiang Keat Tan; Paul Damien James; Kenneth Wilfred Sniderman; Florence Wong
Journal:  J Gastroenterol Hepatol       Date:  2015-02       Impact factor: 4.029

8.  Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.

Authors:  Klaus A Hausegger; Franz Karnel; Buriana Georgieva; Josef Tauss; Horst Portugaller; Hannes Deutschmann; Andrea Berghold
Journal:  J Vasc Interv Radiol       Date:  2004-03       Impact factor: 3.464

9.  Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?

Authors:  James R Rodrigue; David R Nelson; Alan I Reed; Douglas W Hanto; Michael P Curry
Journal:  Prog Transplant       Date:  2011-09       Impact factor: 1.065

10.  Child-Na score: a predictive model for survival in cirrhotic patients with symptomatic portal hypertension treated with TIPS.

Authors:  Hui Chen; Ming Bai; Xingshun Qi; Lei Liu; Chuangye He; Zhanxin Yin; Daiming Fan; Guohong Han
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more
  9 in total

1.  Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).

Authors:  Sergio Maimone; Francesca Saffioti; Roberto Filomia; Angela Alibrandi; Grazia Isgrò; Vincenza Calvaruso; Elias Xirouchakis; Gian Piero Guerrini; Andrew K Burroughs; Emmanuel Tsochatzis; David Patch
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

2.  Comparison of TIPS alone and combined with partial splenic embolization (PSE) for the management of variceal bleeding.

Authors:  Yue-Meng Wan; Yu-Hua Li; Zhi-Yuan Xu; Hua-Mei Wu; Xi-Nan Wu; Ying Xu
Journal:  Eur Radiol       Date:  2019-02-22       Impact factor: 5.315

3.  External Validation of the FIPS Score for Post-TIPS Mortality in a National Veterans Affairs Cohort.

Authors:  Sara E Chapin; David S Goldberg; David E Kaplan; Nadim Mahmud
Journal:  Dig Dis Sci       Date:  2021-11-19       Impact factor: 3.487

4.  Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models.

Authors:  Lichen Xu; Shuangwei Ying; Jianhua Hu; Yunyun Wang; Meifang Yang; Tiantian Ge; Chunhong Huang; Qiaomai Xu; Haihong Zhu; Zhi Chen; Weihang Ma
Journal:  Respir Res       Date:  2018-12-04

5.  Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.

Authors:  Yue-Meng Wan; Yu-Hua Li; Zhi-Yuan Xu; Hua-Mei Wu; Xi-Nan Wu; Ying Xu
Journal:  Clin Transl Gastroenterol       Date:  2018-11-12       Impact factor: 4.488

6.  Factors affecting the outcome of hospitalization among liver cirrhosis patients.

Authors:  Muhammad Irfan; Yasir Mahmud; Rana Muhammad Suhail Khan; Qamar Rafiq; Muhammad Arif Nadeem; Aftab Mohsin
Journal:  Pak J Med Sci       Date:  2019 Sep-Oct       Impact factor: 1.088

7.  Association of Cirrhosis and Cardiomyopathy.

Authors:  Burcu Sezgin; Cigdem Cindoglu; Ahmet Uyanikoglu; Necati Yenice
Journal:  Euroasian J Hepatogastroenterol       Date:  2019 Jan-Jun

Review 8.  Optimizing the Nutritional Support of Adult Patients in the Setting of Cirrhosis.

Authors:  Brandon J Perumpail; Andrew A Li; George Cholankeril; Radhika Kumari; Aijaz Ahmed
Journal:  Nutrients       Date:  2017-10-13       Impact factor: 5.717

9.  A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study.

Authors:  Li Qiang; Jiao Qin; Changfeng Sun; Yunjian Sheng; Wen Chen; Bangdong Qiu; Xin Chen; Yuanfang Chen; Fei Liu; Gang Wu
Journal:  BMC Gastroenterol       Date:  2020-09-16       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.